LACK OF A PHARMACOKINETIC INTERACTION BETWEEN NIFEDIPINE AND THE BETA-ADRENOCEPTOR BLOCKERS METOPROLOL AND ATENOLOL

被引:24
作者
KENDALL, MJ
JACK, DB
LAUGHER, SJ
LOBO, J
SMITH, SR
机构
关键词
D O I
10.1111/j.1365-2125.1984.tb02472.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:331 / 335
页数:5
相关论文
共 19 条
[1]   ANTIHYPERTENSIVE EFFECT OF CARDIOVASCULAR CA2+-ANTAGONIST IN HYPERTENSIVE PATIENTS IN ABSENCE AND PRESENCE OF BETA-ADRENERGIC-BLOCKADE [J].
AOKI, K ;
KONDO, S ;
MOCHIZUKI, A ;
YOSHIDA, T ;
KATO, S ;
KATO, K ;
TAKIKAWA, K .
AMERICAN HEART JOURNAL, 1978, 96 (02) :218-226
[2]   ADDITIVE ANTIANGINAL EFFECT OF VERAPAMIL IN PATIENTS RECEIVING PROPRANOLOL [J].
BASSAN, M ;
WEILERRAVELL, D ;
SHALEV, O .
BRITISH MEDICAL JOURNAL, 1982, 284 (6322) :1067-1070
[3]   NIFEDIPINE AND PROPRANOLOL - A BENEFICIAL DRUG-INTERACTION [J].
DARGIE, HJ ;
LYNCH, PG ;
KRIKLER, DM ;
HARRIS, L ;
KRIKLER, S .
AMERICAN JOURNAL OF MEDICINE, 1981, 71 (04) :676-682
[4]  
DART AM, 1982, BRIT J CLIN PHARMACO, V13, pP587
[5]   NIFEDIPINE IN THE TREATMENT OF DIFFICULT HYPERTENSIVES [J].
DEAN, S ;
KENDALL, MJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (01) :1-5
[6]   EFFECTS OF TREATMENT WITH NIFEDIPINE AND METOPROLOL IN ESSENTIAL-HYPERTENSION [J].
EGGERTSEN, R ;
HANSSON, L .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 21 (05) :389-390
[7]  
EVANS GH, 1973, CLIN PHARMACOL THER, V14, P487
[8]   LACK OF EVIDENCE FOR POLYMORPHISM IN METOPROLOL METABOLISM [J].
JACK, DB ;
WILKINS, M ;
QUARTERMAN, CP .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (02) :188-190
[9]   VARIABILITY OF BETA-BLOCKER PHARMACOKINETICS IN YOUNG VOLUNTEERS [J].
JACK, DB ;
QUARTERMAN, CP ;
ZAMAN, R ;
KENDALL, MJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 23 (01) :37-42
[10]   THE EFFECT OF HYDRALAZINE ON THE PHARMACOKINETICS OF THREE DIFFERENT BETA-ADRENOCEPTOR ANTAGONISTS - METOPROLOL, NADOLOL, AND ACEBUTOLOL [J].
JACK, DB ;
KENDALL, MJ ;
DEAN, S ;
LAUGHER, SJ ;
ZAMAN, R ;
TENNESON, ME .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1982, 3 (01) :47-54